Working… Menu
Trial record 12 of 80 for:    "Adult Acute Lymphocytic Leukemia" | "Antineoplastic Agents, Hormonal"

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01358253
Recruitment Status : Completed
First Posted : May 23, 2011
Last Update Posted : May 20, 2014
Information provided by:
Ruijin Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2012
Actual Study Completion Date : December 2012